NHS Fast-tracks Life-changing Medicines in Landmark UK-US Access Overhaul
From the article
A new series of NHS pilot schemes could give patients access to innovative medicines months earlier while supporting investment in the UK's life sciences industry, as government, the NHS, and pharmaceutical companies work together to accelerate the adoption of cutting-edge treatments.
Continue reading on politicsuk.comYou might also wanna read
2025 Highlights: Accelerating Innovation into Healthcare
bartslifesciences.org·6mo ago
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and
biopharmadive.com·24d ago
UK-US pharmaceuticals deal will divert £45bn from essential NHS services, says doctors' union
Sky News·7d ago
Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
bmj.com·6d agoAnalysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health
This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o
bmj.com·6d agoExpanded Access Allows Compassionate Use of Investigational Drugs When Few Options Exist
ltcnews.com·1mo ago
Analysis: US-UK trade deal could force NHS to divert billions to medicines, critics warn
Analysis claims the US-UK trade deal agreed in December will force the NHS to divert billions from essential services to pay for new medicin
theguardian.com·5d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.